| ACD-RCC | Acquired cystic disease-associated renal cell carcinoma |
| ACKD | Acquired cystic kidney disease |
| ACN | Adult cystic nephroma |
| ADPKD | Autosomal dominant polycystic kidney disease |
| AI | Artificial intelligence |
| AS | Active surveillance |
| AUC | Area under the receiver operating characteristic curve |
| ccRCC | Clear cell renal cell carcinoma |
| CD | Calyceal diverticulum |
| CECT | Contrast-enhanced computed tomography |
| CEUS | Contrast-enhanced ultrasound |
| CI | Confidence interval |
| CRM | Cystic renal mass |
| CT | Computed tomography |
| CUA | Canadian Urological Association |
| ESRD | End-stage renal disease |
| MCRNLMP | Multilocular cystic renal neoplasm of low malignant potential |
| MEST | Mixed epithelial and stromal tumor |
| MRI | Magnetic resonance imaging |
| NICE | National Institute for Health and Care Excellence |
| NIRF | Near-infrared fluorescence |
| PN | Partial nephrectomy |
| pRCC | Papillary renal cell carcinoma |
| RAPN | Robot-assisted partial nephrectomy |
| RCC | Renal cell carcinoma |
| RN | Radical nephrectomy |
| SRC | Simple renal cyst |
| WHO | World Health Organization |
| XGBoost | Extreme gradient boosting |